(CC-HAs) since their introduction into clinical practice. Most of the patients included in these studies had canal stenosis or aural atresia, and the purchase rates of CC-HAs in these patients were relatively high. However, the number of patients with canal-open ears was small, with overall ...
This Clinical Policy Bulletin addresses testosterone undecanoate (Aveed) injection for commercial medical plans. For Medicare criteria, seeMedicare Part B Criteria. Note: Requires Precertification: Precertification of testosterone undecanoate injection (Aveed) is required of all Aetna participating providers a...